Trial Activity Snapshot: Did Australia’s “zero-Covid” plan protect clinical trial activity?
By
Weekly Data
Top 10 precision and personalised medicine companies
| Company | Rank |
|---|---|
| Novartis | 1 |
| Pfizer | 2 |
| Catalent | 3 |
| Johnson & Johnson | 4 |
| Roche | 5 |
| AstraZeneca | 6 |
| Sanofi | 7 |
| Bristol Myers Squibb | 8 |
| Amgen | 9 |
| Gilead Sciences | 10 |
Latest Deals
Expert Analysis
Comment
Avrobio cancels Fabry disease gene therapy research programme following poor results
ByUNION’s orismilast enters Phase IIb and a crowded small molecule market
By
Pharma Technology Focus Magazine
Pharma Technology Focus is free to read on all devices. Subscribe to Pharma Technology Focus and never miss an issue.
Subscribe
GlobalData Reports
